Royalty Pharma
Price & Volume
Stats
See more52W Range | $24.05-$31.09 |
Market Cap | $18.1B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $2.2B |
Revenue Growth (YoY) | 5.3% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $2.54 |
News
See moreYahoo Finance • 4 months ago
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
Yahoo Finance • 5 months ago
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Yahoo Finance • 5 months ago
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Yahoo Finance • 5 months ago
Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now?
About
CEO | Mr. Pablo Gerardo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
